FSME IMMUN NEW Follow-up to Study 205 in Children Aged 6 to 16 Years

Clinical trial NCT00161889 · COMPLETED

Trial details

NCT number: NCT00161889
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Encephalitis, Tick-borne

Start date: 2002-02-01
Enrollment: 615

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.